Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Not applicable Interventional Results available

STEM-PD Open Label Extension (OLE)

ClinicalTrials.gov ID: NCT04799418

Public ClinicalTrials.gov record NCT04799418. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 1:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Non-Invasive Brainstem Modulation for the Treatment of Non-Motor Symptoms in Parkinson's Disease: An Open Label Extension (OLE) Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study seeks to establish the safety and efficacy of extended twice daily time-varying caloric vestibular stimulation treatments for treating symptoms associated with Parkinson's disease. Only participants who completed the STEM-PD randomized controlled trial portion (NCT04797611) are eligible to participate in the open label extension portion.

Study identification

NCT ID
NCT04799418
Recruitment status
Terminated
Study type
Interventional
Phase
Not applicable
Lead sponsor
Scion NeuroStim
Industry
Enrollment
148 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 15, 2022 (Actual)
Primary completion
Feb 24, 2025 (Actual)
Completion
Feb 24, 2025 (Actual)
Last update posted
Jul 3, 2025

2022 – 2025

United States locations

U.S. sites
15
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
Movement Disorder Center of Arizona Scottsdale Arizona 85258 —
Cedars-Sinai Medical Center Los Angeles California 90048 —
Parkinson's Disease and Movement Disorder of Boca Raton Boca Raton Florida 33486 —
Headlands Research Orlando Orlando Florida 32819 —
University of South Florida Tampa Florida 33613 —
University of Kansas Medical Center - Parkinson's Disease Center Kansas City Kansas 66160 —
Quest Research Farmington Hills Michigan 48334 —
Mercy Health Saint Mary's Grand Rapids Michigan 49503 —
University of New Mexico Albuquerque New Mexico 87131 —
Meridian Clinical Research Raleigh North Carolina 27607 —
Cleveland Clinic Cleveland Ohio 44195 —
Medical University of South Carolina Charleston South Carolina 29425 —
Veracity Neuroscience Memphis Tennessee 38157 —
Houston Methodist Neurological Institute Houston Texas 77030 —
Riverside Neurology Specialists Newport News Virginia 23601 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04799418, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 3, 2025 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04799418 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →